Tetra Pharm Technologies ApS: Financial statements 2023
CVR: 40738223
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Tetra Pharm Technologies ApS (CVR 40738223) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 584,758 and a net result of DKK -32,946,869 compared with DKK -7,767,688 the year before. Equity in the 2023 report amounted to DKK 32,087,813. The solvency ratio was 92.8%. The company had 24 employees in the financial year.
- Gross Profit
- DKK 584,758
- Profit/Loss
- DKK -32,946,869
- Equity
- DKK 32,087,813
- Total Assets
- DKK 34,579,545
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 585K | -32.9M | 32.1M | 24 |
| 2022 | - | -510K | -7.8M | 79.9M | 15 |
| 2021 | - | 3.2M | 306K | 9.9M | 6 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Tetra Pharm Technologies ApS has published its annual report for 2022. Gross profit came to DKK -510,296, and the net result was DKK -7,767,688.
About Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Rolf Sass Sørensen and Ulrich Wulff Norden Venge. The board consists of Søren Maarssø (chair), Claus Berner Nielsen, Jesper Breum and Rolf Sass Sørensen. The company's owners include RUMP INVEST ApS, Breum Holding EST. 2016 ApS and BrainFrame ApS. The company has 39 employees (2026). In 2025, the company reported a gross profit of DKK -17,669,007 and a net result of DKK -52,589,605 compared with DKK -55,213,708 the year before. Equity in the 2025 report amounted to DKK -25,844,292.